The groundbreaking therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment